AUZ installs autoclave to boost processing capacity
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
Australian Mines (ASX:AUZ), a Perth-based junior developer, announced it has received a crucial element in the company’s polymetallic processing strategy spread across several projects in Australia.
The project-critical autoclave component is a significant step for AUZ as it builds up momentum and factors the demonstration-size processing plant into its exploration repertoire.
Source: Australian Mines
Any news is speculative at this stage therefore investors considering this stock for their portfolio, should seek professional financial advice.
Having taken delivery of the plant late last year, AUZ installed all the required apparatus over the Christmas period at the Simulus Laboratories site in Perth, Western Australia assisted by Simulus Engineers at the Welshpool laboratory.
With installation complete, the autoclave is now due to complete commissioning later this month. AUZ is hopeful this stage can be quickly completed given that AUZ has previously received a series of quality assurance and control testing results regarding the autoclave’s capabilities. One of the world’s leading inspection, verification, testing and certification companies has already certified that AUZ’s new equipment complies with Australian standards.
At the current time, AUZ is progressing three core projects — the Flemington, Thackaringa and Sconi projects — which are primarily focused on cobalt but have significant potential to contain other metals.
The Sconi Cobalt-Nickel-Scandium Project located in northern Queensland; the Flemington Cobalt-Scandium-Nickel Project in central New South Wales; the greenfields Thackaringa Cobalt Project in western New South Wales.
Source: Australian Mines
The demonstration plant remains is expected to be completed including all commissioning work, before the end of January with the plant expected to commence processing ore previously delivered from trial mining at the Sconi Cobalt-Nickel-Scandium project in Queensland.
According to AUZ, the company will be in a position to process all the ore it has collected from its trial mining activities “within the next three weeks”.
Source: Australian Mines
Australian Mines’ Managing Director, Benjamin Bell, commented: “With the autoclave in place, we look forward to producing commercial grade cobalt sulphate, nickel sulphate and scandium oxide, which will be delivered to the potential off-take partners on a priority basis in February.”
“Following our oversubscribed capital raising late last year, we are fully-funded to complete our Bankable Feasibility Study [BFS] on Sconi and take that project through to a final investment decision, including a comprehensive program of ore processing through the demonstration plant to fine-tune the larger scale engineering studies.”
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.
